85 related articles for article (PubMed ID: 22735680)
21. Identification of cancer stem cells in vincristine preconditioned SGC7901 gastric cancer cell line.
Xue Z; Yan H; Li J; Liang S; Cai X; Chen X; Wu Q; Gao L; Wu K; Nie Y; Fan D
J Cell Biochem; 2012 Jan; 113(1):302-12. PubMed ID: 21913215
[TBL] [Abstract][Full Text] [Related]
22. The Role of Cancer Stem Cells in Recurrent and Drug-Resistant Lung Cancer.
Suresh R; Ali S; Ahmad A; Philip PA; Sarkar FH
Adv Exp Med Biol; 2016; 890():57-74. PubMed ID: 26703799
[TBL] [Abstract][Full Text] [Related]
23. Recurrence cancer stem cells--made by cell fusion?
Dittmar T; Nagler C; Schwitalla S; Reith G; Niggemann B; Zänker KS
Med Hypotheses; 2009 Oct; 73(4):542-7. PubMed ID: 19564079
[TBL] [Abstract][Full Text] [Related]
24. Targeting CSCs within the tumor microenvironment for cancer therapy: a potential role of mesenchymal stem cells.
Bao B; Ahmad A; Li Y; Azmi AS; Ali S; Banerjee S; Kong D; Sarkar FH
Expert Opin Ther Targets; 2012 Oct; 16(10):1041-54. PubMed ID: 22877147
[TBL] [Abstract][Full Text] [Related]
25. MicroRNAs and cancer stem cells: the sword and the shield.
Sun X; Jiao X; Pestell TG; Fan C; Qin S; Mirabelli E; Ren H; Pestell RG
Oncogene; 2014 Oct; 33(42):4967-77. PubMed ID: 24240682
[TBL] [Abstract][Full Text] [Related]
26. Cancer stem cells--important players in tumor therapy resistance.
Colak S; Medema JP
FEBS J; 2014 Nov; 281(21):4779-91. PubMed ID: 25158828
[TBL] [Abstract][Full Text] [Related]
27. Combination therapy with epigenetic-targeted and chemotherapeutic drugs delivered by nanoparticles to enhance the chemotherapy response and overcome resistance by breast cancer stem cells.
Li SY; Sun R; Wang HX; Shen S; Liu Y; Du XJ; Zhu YH; Jun W
J Control Release; 2015 May; 205():7-14. PubMed ID: 25445694
[TBL] [Abstract][Full Text] [Related]
28. Let-7d miRNA Shows Both Antioncogenic and Oncogenic Functions in Osteosarcoma-Derived 3AB-OS Cancer Stem Cells.
Di Fiore R; Drago-Ferrante R; Pentimalli F; Di Marzo D; Forte IM; Carlisi D; De Blasio A; Tesoriere G; Giordano A; Vento R
J Cell Physiol; 2016 Aug; 231(8):1832-41. PubMed ID: 26679758
[TBL] [Abstract][Full Text] [Related]
29. Label retaining cells in cancer--the dormant root of evil?
Schillert A; Trumpp A; Sprick MR
Cancer Lett; 2013 Nov; 341(1):73-9. PubMed ID: 23624300
[TBL] [Abstract][Full Text] [Related]
30. Insights into the regulation of tumor dormancy by angiogenesis in experimental tumors.
Indraccolo S
Adv Exp Med Biol; 2013; 734():37-52. PubMed ID: 23143974
[TBL] [Abstract][Full Text] [Related]
31. Differential expression of CD90 and CD14 stem cell markers in malignant breast cancer cell lines.
Lobba AR; Forni MF; Carreira AC; Sogayar MC
Cytometry A; 2012 Dec; 81(12):1084-91. PubMed ID: 23090904
[TBL] [Abstract][Full Text] [Related]
32. EZH2 is essential for glioblastoma cancer stem cell maintenance.
Suvà ML; Riggi N; Janiszewska M; Radovanovic I; Provero P; Stehle JC; Baumer K; Le Bitoux MA; Marino D; Cironi L; Marquez VE; Clément V; Stamenkovic I
Cancer Res; 2009 Dec; 69(24):9211-8. PubMed ID: 19934320
[TBL] [Abstract][Full Text] [Related]
33. MiR-155 targets TP53INP1 to regulate liver cancer stem cell acquisition and self-renewal.
Liu F; Kong X; Lv L; Gao J
FEBS Lett; 2015 Feb; 589(4):500-6. PubMed ID: 25601564
[TBL] [Abstract][Full Text] [Related]
34. Cancer stem cells and chemosensitivity.
Maugeri-Saccà M; Vigneri P; De Maria R
Clin Cancer Res; 2011 Aug; 17(15):4942-7. PubMed ID: 21622723
[TBL] [Abstract][Full Text] [Related]
35. Crosstalk between DNA repair and cancer stem cell (CSC) associated intracellular pathways.
Skvortsov S; Debbage P; Lukas P; Skvortsova I
Semin Cancer Biol; 2015 Apr; 31():36-42. PubMed ID: 24954010
[TBL] [Abstract][Full Text] [Related]
36. Cancer stem cells: the promise and the potential.
Ajani JA; Song S; Hochster HS; Steinberg IB
Semin Oncol; 2015 Apr; 42 Suppl 1():S3-17. PubMed ID: 25839664
[TBL] [Abstract][Full Text] [Related]
37. Chemical approaches to targeting drug resistance in cancer stem cells.
Sotiropoulou PA; Christodoulou MS; Silvani A; Herold-Mende C; Passarella D
Drug Discov Today; 2014 Oct; 19(10):1547-62. PubMed ID: 24819719
[TBL] [Abstract][Full Text] [Related]
38. Therapeutic targeting of gastrointestinal cancer stem cells.
Stem J; Flickinger JC; Merlino D; Caparosa EM; Snook AE; Waldman SA
Regen Med; 2019 May; 14(4):331-343. PubMed ID: 31025613
[TBL] [Abstract][Full Text] [Related]
39. [Innovative cell-modifying technology targeting cancer stem cell].
Ishii H; Konno M; Kagawa Y; Maeda S; Ohta K; Kano Y; Nishikawa S; Satoh T; Doki Y; Mori M
Rinsho Ketsueki; 2013 May; 54(5):415-22. PubMed ID: 23727678
[No Abstract] [Full Text] [Related]
40. Dormant cancer stem cells hibernate in the mammalian brain.
Siebzehnrubl F; Jeske I; Muller D; Buslei R; Hahnen E; Kaesbauer J; Corbeil D; Huttner H; Appl T; von Horsten S; Blumcke I
J Stem Cells Regen Med; 2007; 2(1):175. PubMed ID: 24692982
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
